New York, NY (PRWEB) September 01, 2014
Parties involved in federally-filed Tylenol lawsuits (http://www.tylenollawsuitcenter.com/) are looking ahead to the litigation’s status conference in September, where issues related to claims involving the pain reliever will be discussed in the Eastern District of Pennsylvania, Bernstein Liebhard LLP reports.
According to a schedule of status conferences posted on the Court’s website, the meeting is scheduled to take place on September 16th, 2014 at 10:00 a.m. This is the latest of several Tylenol conferences that have taken place this year in the U.S. District Court, Eastern District of Pennsylvania, where dozens of lawsuits have been filed against Johnson & Johnson and McNeil Consumer Healthcare. Plaintiffs in Tylenol claims allege serious liver damage caused by the medication’s active ingredient, acetaminophen. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)
“We are looking forward to the Tylenol litigation’s September status conference, as we are speaking on a regular basis with individuals who sustained liver damage allegedly caused by the pain relieving medication,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs including Tylenol. The Firm is offering free legal reviews to individuals who allegedly suffered acetaminophen-related liver damage that resulted in hospitalization, liver transplantation, or death.
Tylenol Lawsuits Alleging Liver Damage
According to a federal Case List updated on August 15th, at least 154 Tylenol lawsuits are now pending in the federal litigation underway in the Eastern District of Pennsylvania. These claims involve alleged instances where individuals took the medications and were hospitalized, needed a liver transplant or even died after taking the medication in accordance with label directions.
A Philadelphia Inquirer report from earlier this year calls attention to the dangers associated with acetaminophen. According to the article published in February 2014, toxic reactions related to the Tylenol ingredient result in 78,000 emergency room visits and 33,000 hospitalizations.*
In August 2013, Bloomberg.com reported that acetaminophen contained in certain over the-counter Tylenol products exceeded the amount limited by the U.S. Food and Drug Administration (FDA) two years earlier for prescription drugs. The federal agency announced in 2011 that these medications were not to contain more than 325 mg of acetaminophen per tablet, but placed no such cap on over-the-counter products. Extra Strength Tylenol tablets each contain 500 mg of the ingredient, according to Bloomberg.**
Individuals who allegedly sustained serious liver damage after taking Tylenol may be eligible to receive compensation for injury-related damages. Learn more about filing a Tylenol lawsuit when you visit Bernstein Liebhard LLP’s website, or call the following number for a free legal review: 800-511-5092.
*articles.philly.com/2014-02-17/news/47382323_1_acetaminophen-poisoning-tylenol-maker-kate-trunk, Philadelphia Inquirer, February 17, 2014
**bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP